Farmakogenetik og skraeddersyet medicinsk behandling

Finn Cilius Nielsen; Niels Borregaard

Farmakogenetik og skraeddersyet medicinsk behandling

Translated title of the contribution: Pharmacogenetics and tailored drug therapy

Finn Cilius Nielsen, Niels Borregaard

Research output: Contribution to journal › Journal article › Research › peer-review

1 Citation (Scopus)

Abstract

Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology.
Udgivelsesdato: 2009-Mar-2

Translated title of the contribution	Pharmacogenetics and tailored drug therapy
Original language	Danish
Journal	Ugeskrift for læger
Volume	171
Issue number	10
Pages (from-to)	790-4
Number of pages	4
ISSN	0041-5782
Publication status	Published - 2009

Bibliographical note

Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines

Cite this

@article{63d2f59009b311df825d000ea68e967b,

title = "Farmakogenetik og skraeddersyet medicinsk behandling",

abstract = "Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2",

author = "Nielsen, {Finn Cilius} and Niels Borregaard",

note = "Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines",

year = "2009",

language = "Dansk",

volume = "171",

pages = "790--4",

journal = "Ugeskrift for l{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "10",

}

TY - JOUR

T1 - Farmakogenetik og skraeddersyet medicinsk behandling

AU - Nielsen, Finn Cilius

AU - Borregaard, Niels

N1 - Keywords: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Pharmacogenetics; Piperazines; Protein Kinase Inhibitors; Pyrimidines

PY - 2009

Y1 - 2009

N2 - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2

AB - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology. Udgivelsesdato: 2009-Mar-2

M3 - Tidsskriftartikel

C2 - 19265602

SN - 0041-5782

VL - 171

SP - 790

EP - 794

JO - Ugeskrift for læger

JF - Ugeskrift for læger

IS - 10

ER -